Parkinson's therapy made from patients' own cells.
1 report so far. New developments are added to this thread as they happen.
- Oct 30, 2026MAKER RAISES $140.6M ON THE STOCK MARKETCompany news · no new data
Maker of a Parkinson's therapy grown from patients' own cells raises $140.6M
Aspen Neuroscience sold shares on the Nasdaq stock market to fund work on a one-time brain cell treatment made from each patient's own skin cells. Its first human trial has 9 planned patients.